
Study: Danisco-Fonterra Probiotic Reduces Colonic Transit Time
Published in the Scandinavian Journal of Gastroenterology, the study centers on the use of Bifidobacterium lactic HN019-a combination product of Danisco’s HOWARU Bifido strain and Fonterra’s DR10 strain.
A collaborative study between Danisco (Copenhagen) and Fonterra (Auckland, New Zealand) provides new support for
Published in the Scandinavian Journal of Gastroenterology, the study centers on the use of Bifidobacterium lactic HN019-a combination product of
Results of the study indicated that colonic transit time was improved in a dose-dependent manner with the probiotic. Transit time decreased by an average 28 hours in the high-dose group and by an average 19 hours in the low-dose group. No reduction was observed in the placebo group and food consumption habits remained similar for all groups.
For more details, visit the study abstract at the link above.
Newsletter
From ingredient science to consumer trends, get the intel you need to stay competitive in the nutrition space—subscribe now to Nutritional Outlook.





